0001209191-19-030638.txt : 20190516 0001209191-19-030638.hdr.sgml : 20190516 20190516193115 ACCESSION NUMBER: 0001209191-19-030638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190514 FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michael Edward L. CENTRAL INDEX KEY: 0001391823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 19833851 MAIL ADDRESS: STREET 1: 618 SHERIDAN SQUARE CITY: EVANSTON STATE: IL ZIP: 60202 FORMER NAME: FORMER CONFORMED NAME: Michael Edward L DATE OF NAME CHANGE: 20070301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-14 0 0000353569 QUIDEL CORP /DE/ QDEL 0001391823 Michael Edward L. 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2019-05-15 4 M 0 834 0.00 A 834 D Restricted Stock Units (Converted) 2019-05-14 4 A 0 1137 0.00 A Common Stock 1137 1137 D Restricted Stock Units (Premium) 2019-05-14 4 A 0 341 0.00 A Common Stock 341 341 D Restricted Stock Units (Equity Grant) 2019-05-14 4 A 0 2100 0.00 A Common Stock 2100 2100 D Reflects release of restricted stock units that were previously reported on Form 4. Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. The restricted stock units vest on the date of the grant, May 14, 2019. The restricted stock units vest on May 14, 2020. Robert J. Bujarski, attorney-in-fact for Edward L. Michael 2019-05-16